While our study unraveled the inhibit function of SFRP1 in oral squamous cancer cells, it is necessary to expose a deeper mechanistic understanding of SFRP1-dependent signaling pathways, which could contribute to a cancer-specific single agent or combination therapy for OSCC. This evidence concerns the gene SFRP1 and cancer.